
Adenomyosis and Fertility: What Patients Need to Know
How can adenomyosis affect conception, IVF, and pregnancy?

Adenomyosis is often explained to patients as a “thickened” or “bulky” uterus that can cause heavy bleeding and painful periods. What many people don’t hear at presumptive diagnosis is a clear answer to the next question: Will this affect my ability to get pregnant or stay pregnant?
Fertility outcomes with adenomyosis vary widely. Party this is because adenomyosis isn’t one single pattern of disease. Some people have focal adenomyosis (more localized), others have diffuse disease (spread throughout the muscle), and many have changes in the junctional zone (JZ), the inner layer of uterine muscle that seems especially important for implantation and early pregnancy. Across multiple recent studies, the overall message is consistent: adenomyosis can make conception and pregnancy harder for some patients, but risk depends on disease features, age/ovarian reserve, and treatment strategy.
How can adenomyosis affect fertility?
1) Implantation may be less reliable (even with good embryos)
Several lines of evidence suggest adenomyosis can interfere with the uterus becoming “receptive” during the implantation window.
A recent single-cell study examining the uterine lining (endometrium) during the mid‑secretory phase—when implantation normally occurs—found patterns consistent with a lining that stays in a more growth/proliferation mode and shows signs of impaired maturation/differentiation. The researchers also reported impaired stromal “decidualization,” a key transformation the lining undergoes to support early pregnancy. This kind of mechanistic research doesn’t tell you what to do tomorrow, but it supports a plausible biological explanation for why some people with adenomyosis struggle with implantation.
2) IVF outcomes are often lower in observational studies
When researchers compare IVF outcomes in people with and without adenomyosis, many observational studies find lower clinical pregnancy and live birth rates and higher miscarriage rates in the adenomyosis groups. A recent review reported pooled results from comparative observational studies showing reduced odds of clinical pregnancy and live birth and increased odds of miscarriage in adenomyosis compared with no adenomyosis.
Importantly, adenomyosis may not affect everyone the same way. Reviews consistently emphasize worse outcomes particularly in diffuse disease and when the junctional zone is involved—details that are often available in ultrasound or MRI reports but usually not well explained to patients.
3) Your “uterus factors” are only part of the picture
One reason adenomyosis sub-fertility factors can feel confusing is that the uterus matters, a lot—but so do ovarian reserve and embryo/lab factors.
A 2026 prediction-modeling study using ultrasound features (based on MUSA criteria) plus clinical variables found only modest ability to predict cumulative live birth after IVF/ICSI from pre-treatment information alone. The strongest predictor was AMH (a marker of ovarian reserve), and among ultrasound features, a regular junctional zone carried more predictive weight than many classic “direct” adenomyosis signs. When the model added IVF-cycle details (like embryo stage and transfer type), prediction improved and embryo-stage variables dominated—underscoring a practical point: adenomyosis matters, but it’s rarely the only driver of IVF success.
If you’re trying to conceive: what are realistic expectations?
For spontaneous conception, high-quality comparative data are limited, and many studies include mixed groups (different ages, different infertility diagnoses, different adenomyosis subtypes). For IVF/ART, the evidence base is larger but still mostly observational and not based on any kind of clinical trials.
What you can take from the combined evidence is this: if you have adenomyosis, it is reasonable to plan for (1) a more individualized approach and (2) possibly needing more time or more than one strategy—especially if imaging suggests diffuse disease or junctional zone disruption.
IVF with adenomyosis: what treatment strategies are supported?
Fertility clinics commonly try to improve outcomes by changing when embryos are transferred and how the uterus is prepared.
Freeze-all and frozen embryo transfer (FET) often makes sense
Across recent reviews, one of the most consistent themes is that many patients with adenomyosis may do better with a freeze-all strategy (create embryos first, freeze them, then transfer later) rather than transferring fresh embryos in the same stimulation cycle.
Why might this help? Ovarian stimulation raises estrogen levels, and adenomyosis is considered estrogen-responsive. The idea behind freezing is to avoid transferring into an inflamed or hormonally “too stimulated” uterine environment and instead transfer in a more controlled cycle.
Multiple retrospective datasets summarized in narrative reviews suggest improved ongoing pregnancy or cumulative outcomes with freeze-all/FET approaches in adenomyosis populations—though we still lack large randomized trials to define exactly who benefits most.
“Ultra-long” GnRH agonist suppression: helpful for some, not all
A common uterine-prep approach is prolonged GnRH agonist downregulation (often 2–3 months) before embryo transfer—sometimes called an “ultra-long” protocol.
Recent evidence syntheses describe this as one of the more consistently supported medical strategies to improve implantation and reduce miscarriage risk, particularly when paired with frozen embryo transfer. At the same time, other analyses—especially those looking at fresh transfer cycles—show mixed results, and there is concern that longer suppression protocols can reduce oocyte yield for some patients. That matters because fewer eggs can mean fewer embryos, which can reduce cumulative live birth chances over multiple transfers.
A practical way to think about it is:
- If your main issue is suspected uterine receptivity, suppression before FET may help.
- If your main limitation is low ovarian reserve or a need to maximize embryo numbers quickly, aggressive suppression before egg retrieval may work against your goals—so some clinics prefer embryo banking first, then uterine suppression, then FET.
Other medical pre-treatments (progestins, dienogest, aromatase inhibitors)
Reviews describe several alternatives or add-ons:
- Progestin-based options (like an LNG-IUS or oral dienogest) appear promising in some observational data for implantation/ongoing pregnancy, but are less extensively studied than GnRH agonists for IVF outcomes.
- GnRH agonist + letrozole (an aromatase inhibitor) is sometimes proposed for severe or “refractory” cases or repeated failures, but supporting evidence is limited to smaller studies/series—best framed as a highly individualized, specialist-level approach rather than a universal standard.
- Continuous combined oral contraceptives are often used for symptom control or scheduling but do not have strong adenomyosis-specific evidence for improving IVF outcomes.
Struggling with Adenomyosis and Fertility?
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your ConsultationFertility-sparing procedures: surgery and thermal ablation—what do outcomes look like?
If symptoms are severe (pain, bleeding) and adenomyosis is believed to be a major driver of infertility, some patients consider procedures aimed at reducing adenomyosis while keeping the uterus.
A 2025 systematic review and meta-analysis pooling non-randomized studies reported that after adenomyomectomy (surgical excision), about 4 in 10 patients had a delivery/live birth on average across studies (pooled delivery rate ~39.5%). After grouped image-guided thermal ablation techniques (such as HIFU/RFA/MWA), the pooled delivery rate was around 32.5%. These numbers are not head-to-head proof that one option is better—they reflect heterogeneous studies with different patient selection and follow-up.
Two additional details patients should know from this body of literature:
- Miscarriage/pregnancy loss is not negligible, and pooled estimates varied widely. In that meta-analysis, pregnancy loss appeared higher after thermal ablation than after adenomyomectomy, but the variation between studies was very large—meaning your individual risk could be quite different depending on age, lesion type, and how pregnancy was achieved (spontaneous vs IVF).
- Cesarean delivery was extremely common after adenomyomectomy in published cohorts (nearly universal in pooled data). This likely reflects both surgical scar considerations and clinician preference for planned cesarean in higher-risk uteruses. It doesn’t automatically mean you personally “must” have a C-section, but it is a strong signal that pregnancy after adenomyomectomy is often managed as higher risk.
- Uterine rupture, especially after an adenomyomectomy, is a very real risk and can occur well before fetal viability. So, for example, a pregnancy may be going well after all the early challenges are successfully navigated. But if a rupture occurs at 16 weeks, there is no way to save the baby and it may lead to uncontrolled hemorrhage on top of that. Similarly, a rupture around term can still result in a dangerous and life threatening hemorrhage. So, these are very real risks of consider.
Pregnancy after IVF or treatment: are there specific risks to watch for?
Most people with adenomyosis who conceive will not experience rare complications—but adenomyosis may identify a subgroup that benefits from more proactive monitoring.
Second-trimester loss signals: possible association with adenomyosis
A 2026 retrospective IVF study focusing on second-trimester pregnancy loss (a rare outcome) found that adenomyosis was more common among those who experienced second-trimester loss than among controls who had live births, among patients with uterine evaluation available. Most losses were linked to PPROM (water breaking early) and cervical insufficiency. This does not prove adenomyosis causes these losses, but it supports discussing whether you should have high-risk obstetric (MFM) involvement, cervical-length monitoring, or other surveillance—especially if you also have uterine scarring or other uterine factors.
Cesarean considerations: uterine torsion may be underrecognized in adenomyosis
A 2026 surgical cohort of patients with adenomyosis undergoing cesarean delivery reported asymptomatic uterine torsion discovered at surgery in a notable minority of cases (especially in focal-type adenomyosis within that cesarean cohort). Patients typically won’t feel this and routine ultrasound often won’t detect it, so the practical takeaway is not “watch for symptoms,” but rather: if you have known adenomyosis and may need a C-section, it can be worth ensuring your team is aware of the diagnosis and prepared for altered anatomy and non-standard incisions if needed.
Contraception note (for future planning): LNG-IUS and ectopic pregnancy
The levonorgestrel IUD (LNG-IUS) is widely used to treat adenomyosis symptoms. Pregnancy with an IUD in place is uncommon, but a 2025 case report highlights that if pregnancy occurs with an LNG-IUS—even if the device is correctly positioned—ectopic pregnancy is a critical rule-out. This is more of a safety reminder: if you have an IUD and a positive pregnancy test, urgent evaluation matters.
Practical takeaways and questions to consider
Use these questions to make appointments more productive and to ensure your plan matches your priorities:
- “Based on my imaging, do I have focal or diffuse adenomyosis, and what does my junctional zone look like?”
- “Is my plan aiming for fresh transfer or freeze-all with FET—and why is that the best fit for my adenomyosis pattern?”
- “Would you recommend 2–3 months of GnRH agonist suppression before transfer? If yes, do we do it before retrieval or after embryos are banked?”
- “How does my AMH/AFC (ovarian reserve) change the pros/cons of prolonged suppression?”
- “If we consider fertility-sparing procedures, am I a candidate for adenomyomectomy or HIFU/RFA? What are the expected symptom benefits, fertility expectations, and pregnancy risks?”
- “If I conceive, should I have early referral to maternal-fetal medicine or additional monitoring (for example, cervical-length checks), given my history and uterine findings?”
What we still don’t know
We still lack enough randomized controlled trials comparing key strategies (fresh vs freeze-all, different suppression regimens, medical vs surgical approaches) specifically in well-characterized adenomyosis subtypes. Many published results come from retrospective cohorts where patients differ in age, ovarian reserve, endometriosis coexistence, infertility duration, and prior treatments—factors that can strongly influence outcomes.
We also don’t yet have a universally accepted way to translate imaging findings into a personalized fertility forecast. Newer tools (including ultrasound feature sets and prediction models) are improving how clinicians describe disease, but current models show only modest predictive ability before treatment—meaning uncertainty is real, and many people will only learn what works through a stepwise plan.
Bottom line: Adenomyosis can affect fertility and pregnancy, but it doesn’t remove your options. The most helpful next step is usually not a one-size-fits-all protocol—it’s clarifying your adenomyosis subtype and your fertility priorities (time, symptoms, ovarian reserve), then choosing a plan that protects both embryo potential and uterine receptivity and considers all risks.
References
Satwik, Verma, Thakur. Strategies to Improve Assisted Reproductive Technique Outcomes in Women with Adenomyosis: A Narrative Review. Journal of Human Reproductive Sciences. 2025. PMID: 40740622 PMCID: PMC12306718
Liu, Wang, Li et al.. Reproductive outcomes after fertility-sparing interventions for symptomatic adenomyosis: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 2025. PMID: 41206447 PMCID: PMC12595728
Martire, Costantini, Zupi et al.. Ectopic Pregnancy with a Normally Located Levonorgestrel-Releasing Intrauterine System in a Woman with Adenomyosis: Case Report and Literature Review. Journal of Clinical Medicine. 2025. PMID: 41517521 PMCID: PMC12786598
Alson, Björnsson, Henic et al.. Machine learning prediction of live birth after IVF using the morphological uterus sonographic assessment group features of adenomyosis. Scientific Reports. 2026. PMID: 41620505 PMCID: PMC12865173
Rubin, Nussbaum, Noruzi et al.. Second-trimester pregnancy loss after in vitro fertilization: risk factors and risk reduction. F&S Reports. 2026. PMID: 41694253 PMCID: PMC12905596
Etrusco, Maiorana, Roncarati et al.. Effect of extended hormonal suppression in patients with adenomyosis undergoing embryo transfer. Frontiers in Reproductive Health. 2026. PMID: 41727871 PMCID: PMC12916556
Yoshida, Iriyama, Ariyoshi et al.. An Unrecognized High Incidence of Asymptomatic Uterine Torsion in Pregnancies with Adenomyosis that Complicate Cesarean Delivery. Reproductive Sciences. 2026. PMID: 41507567 PMCID: PMC12948917
Zhou, He, Xu et al.. Single-cell transcriptomic landscape of the mid-secretory eutopic endometrium reveals receptivity defects in adenomyosis. Journal of Translational Medicine. 2026. PMID: 41787497 PMCID: PMC12964726
Quick Answers
When is menstrual bleeding considered too heavy?
Menstrual flow is generally “too heavy” when it consistently disrupts your life or overwhelms your usual period products—think flooding or soaking through pads/tampons quickly, passing frequent or large clots, needing to double up, or bleeding long enough that you can’t plan around it. Another major clue is fatigue, dizziness, or shortness of breath that can come with iron deficiency from ongoing blood loss. If you’re timing your day around bathrooms, waking at night to change products, or avoiding work, exercise, travel, or sex because of bleeding, that’s not something we consider “normal.”
Heavy bleeding is a symptom, not a diagnosis, and common underlying drivers include adenomyosis, fibroids, hormonal imbalance, and sometimes endometriosis—especially when heavy bleeding shows up with severe cramps or deep pelvic pain. Because imaging and symptoms don’t always match (a scan can look “mild” while symptoms are intense), we take a symptom-led approach and look at the full pattern, including pain, pressure, clots, cycle timing, and any signs of anemia. If your bleeding feels like it’s escalating or you’ve been told to “just live with it,” our team can help you sort out likely causes and build a plan that targets the source—not just the bleeding.
How does estrogen affect the endometrium?
Estrogen is one of the main hormones that drives endometrial growth. In the first half of the menstrual cycle, rising estrogen signals the endometrium to thicken and rebuild after a period, preparing the uterus for a possible pregnancy. It also influences the local immune and inflammatory environment in the uterus, which is part of why hormonal shifts can change bleeding patterns and pain.
When estrogen’s growth signals are strong—and progesterone’s “calming” effect is weaker than expected (often described as progesterone resistance)—the endometrium can behave in a more persistently inflamed, reactive way. This hormone–inflammation pattern is especially relevant in estrogen-dependent conditions like adenomyosis and endometriosis, where tissue similar to the endometrium can contribute to ongoing symptoms. If you’re trying to make sense of heavy bleeding, severe cramping, or cycle-linked pelvic pain, our team can help you connect the hormonal biology to what you’re feeling and review next steps for diagnosis and treatment.
What does advanced adenomyosis mean?
“Advanced adenomyosis” usually means the adenomyosis is more extensive within the uterine muscle—often involving a larger area (diffuse disease), deeper penetration into the myometrium, and/or more pronounced changes like uterine enlargement and tenderness. It’s not the same as “advanced endometriosis,” because adenomyosis doesn’t spread outside the uterus; “advanced” is more about how much of the uterine wall appears affected and how significantly it’s impacting symptoms.
Because adenomyosis doesn’t have a single universally accepted staging system, different clinicians and radiology reports may use “advanced” to summarize imaging features (ultrasound or MRI) and the overall clinical picture—such as heavy bleeding, severe period pain, pelvic pressure, or fertility challenges. In our practice, we focus less on the label and more on what your imaging suggests (diffuse vs focal/adenomyoma, junctional zone changes, uterine size) and what your goals are (pain control, bleeding control, fertility preservation, or definitive treatment). If you’ve been told you have “advanced adenomyosis,” our team can help you interpret what that means in your specific case and map out next steps.
What do endometriosis blood clots look like?
Endometriosis itself doesn’t create a specific, recognizable “type” of blood clot you can identify just by looking. The clots you pass during a period are usually clotted menstrual blood mixed with pieces of shed uterine lining, so they can look dark red to deep brown, jelly-like, stringy, or like thicker “chunks”—and this can happen with or without endometriosis.
What matters more than appearance is the pattern that comes with it. If you’re seeing clots along with heavy or abnormal bleeding, severe or worsening period pain, pain with sex, bowel or bladder symptoms, or pelvic pain that isn’t limited to bleeding days, that combination can fit with endometriosis (and can also overlap with other conditions like adenomyosis or fibroids). If this is what you’re experiencing, our team can help you sort out the likely drivers and discuss what a thorough evaluation and long-term treatment plan can look like—including when minimally invasive excision surgery is worth considering.
Can a retroverted uterus cause pelvic pain or cramps?
A retroverted uterus (a uterus that tilts backward) is a common anatomic variation, and by itself it often doesn’t cause symptoms. Some people do notice more cramping, pelvic pressure, or deep pain with sex—especially in certain positions—but when significant pain is present, we look beyond uterine “tilt” alone.
In our experience, a retroverted uterus is frequently a clue to check for other pain drivers that can coexist, such as endometriosis (which can tether the uterus backward), adenomyosis (which can cause strong, painful uterine contractions), pelvic floor muscle overactivity, or bladder/bowel contributors. If your cramps are severe, worsening over time, occurring outside your period, or paired with deep dyspareunia, bowel/bladder symptoms, heavy bleeding, or infertility, it’s worth a full evaluation rather than stopping at “your uterus is retroverted.” If you’d like, our team can help sort out what’s actually generating your symptoms and outline options—from targeted imaging and diagnostics to definitive surgical treatment when appropriate.

